Amgen's Imdelltra granted FDA accelerated approval to treat small cell lung cancer
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
Stay updated with breaking news from Jay Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
Amgen and AstraZeneca have reported data from a trial that showed the effectiveness of their asthma drug Tezspire in certain patients with COPD.
The agency cleared the drug, called Imdelltra, as a second or later-line treatment for adults with advanced small-cell lung cancer.
-The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small...
U.S. Food and Drug Administration fast-tracks approval for Amgen drug shown to shrink lung tumours